2009Modern Digestion & InterventionRequires access

Referenced value of serum pepsinogen and gastrin-17 in screening chronic atrophic gastritis

Side Liu

Open publisher page 1 citations

Abstract

Objective To search the relationship between serum PGⅠ, PGⅠ/PGⅡratio(PGR)and gas-trin-17 (G-17) and chronic atrophic gastritis and to establish the best cut-off value to screen chronic atrophic gastritis. Methods One hundred patients who underwent endoscopy from May 2007 to December 2007 were recruited according to the inclusion criteria. Based on histopathologic diagnosis criteria, these patients were di-vided into two groups : One was control group (n = 48), the other was chronic atrophic gastritis group(n = 52). Serum levels of PGⅠ, PGⅡand G-17 were assayed by immunoradiometic assay and radioimmunoassay. Re-sult Serum levels of PGⅠ, G-17 and PGR value were significantly decreased in chronic atrophic gastritis group compared to those in the control group (P 0.001). Serum level of G-17 in patients with atrophic corpus gastritis and multifocal atrophic gastritis were significantly decreased compared to those in patients with at-rophic antral gastritis (P 0.001). Serum levels of PGⅠand PGR in patients with atrophic antral gastritis and multifocal atrophic gastritis were significantly decreased compared to those in patients with atrophic corpus gastritis (P 0.001). According to the ROC curves, the best cut-off values of PGⅠ, PGR and G-17 were 82.2 μg/L(sensitivity 85%, specificity 73%), 7.5 (sensitivity 89%, specificity71%) and 8.3 pmol/L (sensitivity 85%, specificity73%), respectively. Conclusion Detection of serum PG and G-17 levels can be used as a non-in-vasive way to screen chronic atrophic gastritis and this method is fit the mass survey in large-scale of popula-tion.

About this research paper

What this paper is about

Objective To search the relationship between serum PGⅠ, PGⅠ/PGⅡratio(PGR)and gas-trin-17 (G-17) and chronic atrophic gastritis and to establish the best cut-off value to screen chronic atrophic gastritis. Methods One hundred patients who underwent endoscopy from May 2007 to December 2007 were recruited according to the inclusion criteria. Based on histopathologic diagnosis criteria, these patients were di-vided into two groups : One was control group (n = 48), the other was chronic atrophic gastritis group(n = 52). Serum levels of PGⅠ, PGⅡand G-17 were assayed by immunoradiometic assay and radioimmunoassay. Re-sult Serum levels of PGⅠ, G-17 and PGR value were significantly decreased in chronic atrophic gastritis group compared to those in the control group (P 0.001). Serum level of G-17 in patients with atrophic corpus gastritis and multifocal atrophic gastritis were significantly decreased compared to those in patients with at-rophic antral gastritis (P 0.001). Serum levels of PGⅠand PGR in patients with atrophic antral gastritis and multifocal atrophic gastritis were significantly decreased compared to those in patients with atrophic corpus gastritis (P 0.001). According to the ROC curves, the best cut-off values of PGⅠ, PGR and G-17 were 82.2 μg/L(sensitivity 85%, specificity 73%), 7.5 (sensitivity 89%, specificity71%) and 8.3 pmol/L (sensitivity 85%, specificity73%), respectively. Conclusion Detection of serum PG and G-17 levels can be used as a non-in-vasive way to screen chronic atrophic gastritis and this method is fit the mass survey in large-scale of popula-tion.

Why it matters

OpenAlex reports 1 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective To search the relationship between serum PGⅠ, PGⅠ/PGⅡratio(PGR)and gas-trin-17 (G-17) and chronic atrophic gastritis and to establish the best cut-off value to screen chronic atrophic gastritis. Methods One hundred patients who underwent endoscopy from May 2007 to December 2007 were recruited according to the inclusion criteria. Based on histopathologic diagnosis criteria, these patients were di-vided into two groups : One was control group (n = 48), the other was chronic atrophic gastritis group(n = 52). Serum levels of PGⅠ, PGⅡand G-17 were assayed by immunoradiometic assay and radioimmunoassay. Re-sult Serum levels of PGⅠ, G-17 and PGR value were significantly decreased in chronic atrophic gastritis group compared to those in the control group (P 0.001). Serum level of G-17 in patients with atrophic corpus gastritis and multifocal atrophic gastritis were significantly decreased compared to those in patients with at-rophic antral gastritis (P 0.001). Serum levels of PGⅠand PGR in patients with atrophic antral gastritis and multifocal atrophic gastritis were significantly decreased compared to those in patients with atrophic corpus gastritis (P 0.001). According to the ROC curves, the best cut-off values of PGⅠ, PGR and G-17 were 82.2 μg/L(sensitivity 85%, specificity 73%), 7.5 (sensitivity 89%, specificity71%) and 8.3 pmol/L (sensitivity 85%, specificity73%), respectively. Conclusion Detection of serum PG and G-17 levels can be used as a non-in-vasive way to screen chronic atrophic gastritis and this method is fit the mass survey in large-scale of popula-tion.

Key concepts: Atrophic gastritis, Gastroenterology, Internal medicine, Medicine, Gastritis, Gastrin, Pepsin, Antrum

Related papers

Back to paper searchBrowse research topicsOriginal source
Referenced value of serum pepsinogen and gastrin-17 in screening chronic atrophic gastritis — Research Paper | ScholarLens